Lexeo Therapeutics Inc. Common Stock

LXEO | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.07

-$0.01 (-0.25%)

At close: Sep 22, 2026, 4:00 PM ET

$4.07

$0 (0.00%)

After-hours: Sep 22, 2026, 6:15 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $320.37M

Enterprise Value $115.48M

Beta 1.50

Average Volume 857.06K

Shares Outstanding (Diluted) 85.63M

Shares Change YoY 96.51%

Institutional Ownership 98.41%

Exchange NASDAQ

ISIN US52886X1072

Price Performance

Price Change 1M -16.4%

Price Change 3M -17.1%

Price Change 6M -28.7%

Price Change YTD -57.5%

Price Change 1Y -23.2%

Price Change 3Y -59.4%

Price Change 5Y -59.4%

1M CAGR (ann.) -15.2%

1Y CAGR (ann.) -25.3%

5Y CAGR (ann.) N/A

All-Time CAGR -26.8%

Valuation

PE Ratio -3.55

Forward PE N/A

PEG Ratio -0.03

Forward PEG -0.29

PS Ratio N/A

Forward PS 46.60

PB Ratio 1.36

P/FCF Ratio -3.61

P/Adj. FCF Ratio -3.13

P/OCF Ratio -3.96

EV/Sales N/A

EV/EBIT -1.33

EV/EBITDA -1.35

EV/FCF -1.30

Earnings Yield -28.2%

FCF Yield -27.7%

Adj. FCF Yield -32.0%

Financial Health

Net Cash $211.7M

Total Debt $6.81M

Cash & Short-Term Investments $211.7M

Total Assets $254.9M

Current Ratio 13.89

Quick Ratio 13.89

Debt / Equity Ratio 0.03

Debt / EBITDA -0.08

Debt / FCF -0.08

OCF / Debt -12.97

Interest Coverage -689.25

Altman Z-Score 7.17

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -15.6%

Returns

Return on Assets -34.2%

Return on Equity -41.9%

Return on Invested Capital -39.3%

Return on Capital Employed -39.8%

Return on Tangible Assets -34.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -85.8%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 33.2%

EPS CAGR 5Y -1.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y -15.3%

FCF CAGR 5Y -19.9%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 49.6%

Revenue Growth Next 3Y N/A

Earnings Date Dec 13, 2026

EPS Estimate (next Q) -$0.33

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $21.13

Price Target Upside 417.9%

Cash Flow

Operating Cash Flow $-88.37M

Free Cash Flow $-88.7M

Adj. Free Cash Flow $-102.51M

FCF Per Share -$1.04

OCF Per Share -$1.03

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-546K

Operating Income $-95.12M

EBITDA $-85.44M

Net Income $-87.27M

EPS (Diluted) -$1.15

Revenue / Employee N/A

Profit / Employee $-1.39M

Employees 63